ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $168,000 | -26.6% | 21,600 | -14.3% | 0.00% | -50.0% |
| Q3 2021 | $229,000 | +53.7% | 25,200 | +152.0% | 0.01% | +100.0% |
| Q4 2020 | $149,000 | +40.6% | 10,000 | -45.1% | 0.00% | -33.3% |
| Q2 2020 | $106,000 | -85.8% | 18,200 | -48.8% | 0.01% | -88.0% |
| Q1 2020 | $748,000 | +165.2% | 35,566 | +159.6% | 0.05% | +233.3% |
| Q4 2019 | $282,000 | -58.7% | 13,700 | -90.9% | 0.02% | -73.2% |
| Q3 2019 | $683,000 | +5.9% | 150,500 | -0.3% | 0.06% | +12.0% |
| Q2 2019 | $645,000 | +73.4% | 151,000 | -40.5% | 0.05% | +51.5% |
| Q1 2019 | $372,000 | – | 253,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |